Insiders · Profile

New Enterprise Associates 16, L.P.

10% owner at Marker Therapeutics · 10% owner at Trevi Therapeutics · 10% owner at Mirum Pharmaceuticals. Filing since 9 May 2019. CIK 0001694560

Company
Date
Role
Action
Shares
Amount
Of holding
23 Dec 2024
10% owner
Bought
554,250
$1.77M
51.7%
11 Apr 2022
10% owner
Bought
2,631,578
$5.00M
33.8%
18 Oct 2021
10% owner
Bought
1,851,852
no price
31.2%
16 Mar 2021
10% owner
Bought
5,714,285
$10.00M
114%
3 Apr 2020
10% owner
Sold, plan not stated
564
$1.50K
0.0%
22 Jul 2019
10% owner
Bought
450,000
$6.75M
12.0%
9 May 2019
10% owner
Bought
2,500,000
$25.00M
129%
7 decisions on file.